You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 8, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
Mary Morse Linn1, Robert A Ball, Ann Maradiegue
1Adult Practice Program, George Mason University, Fairfax, VA, USA.
The prostate-specific antigen (PSA) blood test is a common tool for detecting early prostate cancer. However, its effectiveness is debated due to false positives and differing medical recommendations, requiring individualized patient assessment.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: